Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
Von Willebrand disease (vWD) is an inherited bleeding disorder like hemophilia. It is caused by a defect or deficiency of a blood-clotting protein, called the von Willebrand factor. The von Willebrand factor is essential for the beginning stages of clotting and acts like glue to help the platelets stick together and form a blood clot.
How Boston Children's Hospital approaches von Willebrand disease
Your child will receive treatment for vWD at the Boston Hemophilia Center, the largest hemophilia program in New England.
Reviewed by Kapil Saxena, MD, and Ellis Neufeld, MD, PhD
© Boston Children’s Hospital 2013
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”